Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Miguel BernardoFernando Rico-VillademorosClemente García-RizoRosa RojoRicardo Gómez-HuelgasPublished in: Advances in therapy (2021)
Although there are relevant differences among SGAs concerning the risk of metabolic disorders, it appears that none of the SGAs included in our review are fully devoid of these disturbances.